Related Experiment Video
Updated: Apr 6, 2026
05:45
Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
6.5K
Leptin Does Not Mediate Hypertension Associated With Human Obesity
Rebecca J Brown1, Cristina Adelia Meehan1, Phillip Gorden1
1Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Cell
|August 2, 2015
Summary
Hypertension and obesity are linked, but the hormone leptin may not be the cause in humans. A different, unidentified factor is likely responsible for hypertension in people.
Area of Science:
- Physiology
- Endocrinology
- Cardiovascular Science
Background:
- Obesity and hypertension are recognized comorbidities.
- Leptin, a hormone regulating appetite and metabolism, has been implicated in mediating the hypertension-obesity link in rodent models.
- The precise mechanisms underlying this association in humans remain unclear.
Purpose of the Study:
- To investigate the role of leptin in the relationship between hypertension and obesity in humans.
- To explore potential alternative factors contributing to hypertension in obese individuals.
Main Methods:
- This study reviews existing literature and discusses proposed mechanisms.
- Comparative analysis of rodent and human physiological responses to obesity and hypertension.
Main Results:
- Evidence suggests leptin's role in mediating hypertension in mice.
- Data indicates that this leptin-mediated pathway may not be conserved in humans.
- A significant, yet unidentified, factor is likely responsible for hypertension in the human population.
Conclusions:
- The established link between obesity and hypertension in humans may involve mechanisms distinct from those observed in mice.
- Further research is required to identify the specific factor(s) responsible for hypertension in obese humans.
Related Concept Videos
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
287
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
287
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
394
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
394
01:21Drug Dosing: Obese Patients
343
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
343
01:30Regulation of Food Intake
3.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.2K
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:24Overview of Lipid Metabolism
6.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.8K